A prospective multicenter study on cutaneous reactions reported after Sinopharm COVID-19 vaccination.

Ahmed Shawky,Emad M Elrewiny,Khaled Gharib,Manar Sallam,Mofreh Mansour,Mahmoud A Rageh

International journal of dermatology（2023）

引用 1|浏览5

暂无评分

摘要

Because Sinopharm's cutaneous reactions are frequently mild and self-limiting, vaccination should not be discouraged based on these findings. If the first vaccine dose creates a cutaneous reaction, there is no need to skip the second dose.

查看译文

关键词

cutaneous reactions,sinopharm,vaccination,<scp>covid</scp>‐19

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要